Tofersen-d27
Tofersen-d27 (BIIB067-d27) is the deuterium labeled Tofersen. Tofersen (BIIB067) is an antisense oligonucleotide that mediates RNase H-dependent degradation of superoxide dismutase 1 (SOD1) mRNA to reduce the synthesis of SOD1 protein. Tofersen can be used for the research of amyotrophic lateral sclerosis (ALS).
Product Specifications
Product Name Alternative
BIIB067-d27; ISIS-SOD1Rx-d27; ISIS 333611-d27
UNSPSC
12352208
Target
DNA/RNA Synthesis; Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage; Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Smiles
[Tofersen-d27]
Molecular Formula
C230H290D27N72O123P19S15
Molecular Weight
7155.18
References & Citations
[1]Miller T, et, al. Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N Engl J Med. 2020 Jul 9;383 (2) :109-119. |[2]McCampbell A, et, al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest. 2018 Aug 1;128 (8) :3558-3567.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680096-500 1x 500 µL
Histone H1 (AE-4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400820-500 1x 500 µL
Caldesmon, HMW (h-Caldesmon) (CALD1/820), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472344-500 1x 500 µL
CD44v9 (Marker of Tumor Metastasis) (CD44v9/2344R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400034-500 1x 500 µL
Cytokeratin 8/18 (C-51), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881208-500 1x 500 µL
HLA-DRB (LN-3 + HLA-DRB/1067), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details